Polistena, B., Spandonaro, F., Capra, R., Fantaccini, S., Santoni, L., Zimatore, G., & Gasperini, C. (2019). The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study. Global and Regional Health Technology Assessment, 6(1). https://doi.org/10.33393/grhta.2019.463